Leef Brands (LEEEF) EBITDA Margin (2025 - 2026)
Leef Brands (LEEEF) posted EBITDA Margin of 13.69% for Q1 2026, up 167.45% sequentially from 20.3% in Q1 2025, and up 3399.0% YoY from 0.39% in Q1 2025.
Leef Brands (LEEEF) EBITDA Margin (2025 - 2026) Analysis & Trends
Leef Brands has reported EBITDA Margin for 2 years, with the latest figure at 13.69% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Leef Brands | 58.70 Mn | 53.75 Mn | 2.41 Mn | -19.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.33% |
| Mar 31, 2026 | 13.69% |
| Mar 31, 2025 | -20.30% |